Immune-complex-membranoproliferative Glomerulonephritis
3 clinical trials · Condition
◉ Watch Immune-complex-membranoproliferative Glomerulonephritis
| Record | Firm | Date |
|---|---|---|
| Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN (NCT03955445) | Novartis Pharmaceuticals | 2019-10-03 |
| Non-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 Study (NCT03723512) | Mario Negri Institute for Pharmacological Research | 2018-12-06 |
| A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471 (NCT03459443) | Alexion Pharmaceuticals, Inc. | 2018-06-20 |
Track Immune-complex-membranoproliferative Glomerulonephritis automatically
Every clearance here is in the API, with alerts when new ones post.